Es gab 50 kürzliche Insider-Transaktionen für Annexon, Inc. (ANNX), darunter 33 Käufe und 17 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $22.84M und die gesamten Insider-Verkäufe auf $401.75K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Carson William H., Lew Jennifer, Dananberg Jamie. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ANNX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-10 |
Carson William H. |
Director |
Informierter Kauf |
8,000 |
$5.67 |
$45.36K |
62,405 |
| 2026-03-02 |
Lew Jennifer |
EVP & Chief Financial Officer |
Informierter Verkauf |
5,565 |
$5.42 |
$30.16K |
170,700 |
| 2026-03-02 |
Dananberg Jamie |
Chief Medical Officer |
Informierter Verkauf |
5,820 |
$5.43 |
$31.6K |
123,582 |
| 2026-03-02 |
Overdorf Michael |
EVP & Chief Business Officer |
Informierter Verkauf |
4,339 |
$5.42 |
$23.52K |
182,625 |
| 2026-03-02 |
Yednock Ted |
EVP & Chief Innovation Officer |
Informierter Verkauf |
5,566 |
$5.42 |
$30.17K |
154,161 |
| 2026-03-02 |
Artis Dean Richard |
EVP & Chief Scientific Officer |
Informierter Verkauf |
5,894 |
$5.43 |
$32K |
180,093 |
| 2026-02-19 |
Lew Jennifer |
EVP & Chief Financial Officer |
RSU-Zuteilung |
62,500 |
- |
- |
176,265 |
| 2026-02-19 |
Dananberg Jamie |
Chief Medical Officer |
RSU-Zuteilung |
56,250 |
- |
- |
129,402 |
| 2026-02-19 |
Love Douglas |
President and CEO |
RSU-Zuteilung |
1,250,000 |
$5.10 |
$6.38M |
1,250,000 |
| 2026-02-19 |
Overdorf Michael |
EVP & Chief Business Officer |
RSU-Zuteilung |
62,500 |
- |
- |
186,964 |
| 2026-02-19 |
Yednock Ted |
EVP & Chief Innovation Officer |
RSU-Zuteilung |
62,500 |
- |
- |
159,727 |
| 2026-02-19 |
Artis Dean Richard |
EVP & Chief Scientific Officer |
RSU-Zuteilung |
62,500 |
- |
- |
185,987 |
| 2026-02-18 |
Lew Jennifer |
EVP & Chief Financial Officer |
Informierter Verkauf |
7,851 |
$5.11 |
$40.12K |
113,765 |
| 2026-02-18 |
Dananberg Jamie |
Chief Medical Officer |
Informierter Verkauf |
5,290 |
$5.10 |
$26.98K |
73,152 |
| 2026-02-18 |
Overdorf Michael |
EVP & Chief Business Officer |
Informierter Verkauf |
6,225 |
$5.10 |
$31.75K |
124,464 |
| 2026-02-18 |
Yednock Ted |
EVP & Chief Innovation Officer |
Informierter Verkauf |
7,857 |
$5.11 |
$40.15K |
97,227 |
| 2026-02-18 |
Artis Dean Richard |
EVP & Chief Scientific Officer |
Informierter Verkauf |
5,290 |
$5.10 |
$26.98K |
123,487 |
| 2025-12-30 |
Carson William H. |
Director |
Informierter Kauf |
4,115 |
$5.02 |
$20.66K |
54,405 |
| 2025-12-01 |
Choi Jung |
Director |
Informierter Kauf |
33,000 |
$4.19 |
$138.27K |
33,000 |
| 2025-12-01 |
Carson William H. |
Director |
Informierter Kauf |
4,115 |
$4.47 |
$18.39K |
50,290 |
| 2025-11-21 |
Satter Muneer A |
Director |
Informierter Kauf |
422,613 |
$4.28 |
$1.81M |
9,728,637 |
| 2025-11-20 |
Satter Muneer A |
Director |
Informierter Kauf |
400,000 |
$4.48 |
$1.79M |
9,306,024 |
| 2025-11-19 |
Satter Muneer A |
Director |
Informierter Kauf |
500,000 |
$3.94 |
$1.97M |
8,906,024 |
| 2025-11-18 |
Satter Muneer A |
Director |
Informierter Kauf |
500,000 |
$3.18 |
$1.59M |
8,406,024 |
| 2025-11-17 |
Satter Muneer A |
Director |
Informierter Kauf |
500,000 |
$2.99 |
$1.5M |
7,906,024 |
| 2025-10-30 |
Carson William H. |
Director |
Informierter Kauf |
4,115 |
$3.17 |
$13.04K |
46,175 |
| 2025-09-30 |
Carson William H. |
Director |
Informierter Kauf |
4,115 |
$3.05 |
$12.55K |
42,060 |
| 2025-09-02 |
Carson William H. |
Director |
Informierter Kauf |
4,115 |
$2.09 |
$8.6K |
37,945 |
| 2025-07-30 |
Carson William H. |
Director |
Informierter Kauf |
4,115 |
$2.43 |
$10K |
33,830 |
| 2025-07-14 |
Lew Jennifer |
EVP & Chief Financial Officer |
Informierter Verkauf |
1,117 |
$2.58 |
$2.88K |
121,616 |
| 2025-07-14 |
Overdorf Michael |
EVP & Chief Business Officer |
Informierter Verkauf |
853 |
$2.61 |
$2.23K |
130,689 |
| 2025-07-14 |
Yednock Ted |
EVP & Chief Innovation Officer |
Informierter Verkauf |
1,116 |
$2.58 |
$2.88K |
105,084 |
| 2025-06-30 |
Carson William H. |
Director |
Informierter Kauf |
4,115 |
$2.46 |
$10.12K |
29,715 |
| 2025-06-05 |
Wiggans Thomas G |
Director |
RSU-Zuteilung |
55,000 |
$2.55 |
$140.25K |
55,000 |
| 2025-06-05 |
Satter Muneer A |
10 Percent Owner |
RSU-Zuteilung |
55,000 |
$2.55 |
$140.25K |
55,000 |
| 2025-06-05 |
Jones William A Jr |
Director |
RSU-Zuteilung |
55,000 |
$2.55 |
$140.25K |
55,000 |
| 2025-06-05 |
Waddill William D. |
Director |
RSU-Zuteilung |
55,000 |
$2.55 |
$140.25K |
55,000 |
| 2025-06-05 |
Choi Jung |
Director |
RSU-Zuteilung |
55,000 |
$2.55 |
$140.25K |
55,000 |
| 2025-06-05 |
Carson William H. |
Director |
RSU-Zuteilung |
55,000 |
$2.55 |
$140.25K |
55,000 |
| 2025-06-05 |
Cockroft Bettina M. |
Director |
RSU-Zuteilung |
55,000 |
$2.55 |
$140.25K |
55,000 |
| 2025-02-27 |
Lew Jennifer |
EVP & Chief Financial Officer |
RSU-Zuteilung |
272,575 |
$2.50 |
$681.44K |
272,575 |
| 2025-02-27 |
Dananberg Jamie |
Chief Medical Officer |
RSU-Zuteilung |
228,225 |
$2.50 |
$570.56K |
228,225 |
| 2025-02-27 |
Love Douglas |
President and CEO |
RSU-Zuteilung |
1,300,000 |
$2.50 |
$3.25M |
1,300,000 |
| 2025-02-27 |
Overdorf Michael |
EVP & Chief Business Officer |
RSU-Zuteilung |
272,575 |
$2.50 |
$681.44K |
272,575 |
| 2025-02-27 |
Yednock Ted |
EVP & Chief Innovation Officer |
RSU-Zuteilung |
272,575 |
$2.50 |
$681.44K |
272,575 |
| 2025-02-27 |
Artis Dean Richard |
EVP & Chief Scientific Officer |
RSU-Zuteilung |
272,575 |
$2.50 |
$681.44K |
272,575 |
| 2025-02-18 |
Lew Jennifer |
EVP & Chief Financial Officer |
Informierter Verkauf |
6,912 |
$2.92 |
$20.18K |
77,770 |
| 2025-02-18 |
Dananberg Jamie |
Chief Medical Officer |
Informierter Verkauf |
5,521 |
$2.96 |
$16.34K |
33,479 |
| 2025-02-18 |
Overdorf Michael |
EVP & Chief Business Officer |
Informierter Verkauf |
6,618 |
$2.95 |
$19.52K |
86,579 |
| 2025-02-18 |
Yednock Ted |
EVP & Chief Innovation Officer |
Informierter Verkauf |
8,345 |
$2.91 |
$24.28K |
61,237 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
